Hypermagnesaemia, or elevated magnesium levels in the blood, is an uncommon but potentially serious condition that requires prompt medical attention. Understanding how to remove excess magnesium from the body is crucial for those at risk, particularly individuals with impaired kidney function or those taking magnesium-containing medications. Whilst healthy kidneys efficiently eliminate surplus magnesium, certain circumstances—such as chronic kidney disease, excessive supplementation, or use of magnesium-rich laxatives and antacids—can lead to dangerous accumulation. This article explores the medical treatments available to reduce elevated magnesium levels, when to seek urgent help, and practical prevention strategies to maintain safe magnesium balance.

Understanding Excess Magnesium in the Body

Hypermagnesaemia, or elevated magnesium levels in the blood, is a relatively uncommon condition that occurs when serum magnesium concentrations exceed the normal range (typically 0.7–1.0 mmol/L, though laboratory reference ranges may vary). Unlike magnesium deficiency, which is more frequently encountered in clinical practice, excess magnesium typically develops only under specific circumstances and rarely occurs from dietary intake alone in individuals with normal kidney function.

The kidneys play a crucial role in maintaining magnesium homeostasis by filtering and excreting excess magnesium through urine. In healthy individuals, the renal system efficiently eliminates surplus magnesium, making it difficult to accumulate dangerous levels through food or standard supplementation. However, when kidney function is impaired—particularly in chronic kidney disease (CKD) stages 4–5 or acute kidney injury—the body's ability to excrete magnesium becomes compromised, leading to potential accumulation.

Other risk factors for developing hypermagnesaemia include excessive use of magnesium-containing medications such as antacids (e.g., magnesium hydroxide), laxatives (magnesium sulphate), or intravenous magnesium therapy used in conditions like pre-eclampsia. Elderly patients and those with reduced gastrointestinal motility may also be at increased risk. Understanding these mechanisms is essential for both prevention and appropriate management.

The severity of hypermagnesaemia is generally classified based on serum levels, though classifications may vary between clinical sources: mild (1.0–2.0 mmol/L), moderate (2.0–4.0 mmol/L), and severe (>4.0 mmol/L). Severe cases constitute a medical emergency requiring immediate intervention, as magnesium affects neuromuscular transmission and cardiac conduction, potentially leading to life-threatening complications if left untreated.

Symptoms of High Magnesium Levels (Hypermagnesaemia)

The clinical presentation of hypermagnesaemia varies considerably depending on the serum magnesium concentration and the rate at which levels have risen. Mild elevations may be entirely asymptomatic and discovered incidentally during routine blood tests, whilst moderate to severe hypermagnesaemia produces progressively serious symptoms affecting multiple organ systems.

Early and mild symptoms may include:

• Nausea and vomiting

• Facial flushing and warmth

• Lethargy and generalised weakness

• Reduced appetite

• Mild confusion or difficulty concentrating

As magnesium levels continue to rise, neuromuscular symptoms become more pronounced due to magnesium's effect on nerve and muscle function. Patients may experience muscle weakness that can progress to flaccid paralysis, reduced or absent deep tendon reflexes (hyporeflexia or areflexia), and difficulty with coordination. These effects occur because excess magnesium blocks neuromuscular transmission by competing with calcium at the neuromuscular junction.

Cardiovascular manifestations represent the most serious complications of hypermagnesaemia. Magnesium affects cardiac conduction, and elevated levels can cause:

• Hypotension (low blood pressure)

• Bradycardia (abnormally slow heart rate)

• Electrocardiogram (ECG) changes, including prolonged PR interval and widened QRS complex

• In severe cases, complete heart block or cardiac arrest

Gastrointestinal effects may include reduced motility, potentially leading to ileus (intestinal paralysis) and urinary retention in some cases.

Respiratory depression may occur in severe hypermagnesaemia as the respiratory muscles become affected, potentially leading to hypoventilation and respiratory failure. Central nervous system depression can progress from drowsiness to confusion, and ultimately to coma in extreme cases. These severe manifestations typically occur when serum magnesium exceeds 4.0–5.0 mmol/L and require emergency medical intervention.

Medical Treatments to Remove Excess Magnesium

The management of hypermagnesaemia depends on the severity of elevation, the presence of symptoms, and the patient's renal function. Treatment aims to prevent further magnesium absorption, enhance excretion, and antagonise the effects of excess magnesium on vital organs.

Immediate discontinuation of all magnesium-containing products is the first essential step. This includes stopping magnesium supplements, antacids, laxatives, and any intravenous magnesium infusions. A thorough medication review should be conducted to identify all potential sources, including over-the-counter preparations that patients may not recognise as containing magnesium.

Intravenous calcium gluconate serves as a direct antagonist to magnesium's effects, particularly on the cardiovascular and neuromuscular systems. Typically administered as 10 mL of 10% calcium gluconate given slowly over 5–10 minutes with ECG monitoring, this treatment provides rapid but temporary reversal of magnesium's toxic effects on cardiac conduction and neuromuscular transmission. Calcium does not lower magnesium levels but counteracts its physiological effects whilst other elimination strategies take effect. Repeat doses may be necessary. In some cases, calcium chloride may be used via a central venous line.

Intravenous fluid therapy with normal saline (0.9% sodium chloride) promotes renal magnesium excretion in patients with adequate kidney function. Volume expansion increases glomerular filtration rate and reduces tubular reabsorption of magnesium. This approach is most effective in patients with mild to moderate hypermagnesaemia and preserved renal function.

Loop diuretics such as furosemide may be administered alongside intravenous fluids to further enhance urinary magnesium excretion in patients with preserved urine output. These medications inhibit magnesium reabsorption in the loop of Henle, increasing elimination. However, careful monitoring of fluid balance and electrolytes (particularly potassium and calcium) is necessary, as diuretics can cause additional electrolyte disturbances. This approach has limited efficacy in patients with severe renal impairment or anuria.

Haemodialysis represents the most effective method for rapidly removing excess magnesium and is indicated in severe hypermagnesaemia, particularly when accompanied by significant symptoms, renal failure, or cardiovascular compromise. Dialysis uses a magnesium-free or low-magnesium dialysate to create a concentration gradient that efficiently removes magnesium from the blood. This intervention is life-saving in critical cases and may need to continue until magnesium levels normalise and kidney function improves or stabilises.

Patients should report any suspected side effects from magnesium-containing medicines to the MHRA Yellow Card Scheme.

When to Seek Medical Help for High Magnesium

Recognising when to seek medical attention for suspected hypermagnesaemia is crucial, as severe cases can rapidly progress to life-threatening complications. Certain situations warrant immediate medical assessment, whilst others require prompt but less urgent evaluation.

Seek emergency medical help (call 999 or attend A&E immediately) if experiencing:

• Severe muscle weakness or inability to move limbs

• Difficulty breathing or shortness of breath

• Irregular heartbeat, very slow pulse, or chest pain

• Severe dizziness, fainting, or loss of consciousness

• Extreme drowsiness or confusion

• Symptoms developing after taking large amounts of magnesium-containing laxatives or antacids

These symptoms may indicate dangerously elevated magnesium levels requiring urgent intervention, particularly intravenous calcium and potentially dialysis.

Contact your GP or NHS 111 within 24 hours if you have:

• Chronic kidney disease and are taking magnesium supplements or magnesium-containing medications

• Persistent nausea, vomiting, or unexplained lethargy whilst using magnesium products

• Known risk factors for hypermagnesaemia (such as reduced kidney function) and new symptoms of weakness or confusion

• Concerns about medication interactions or cumulative magnesium intake from multiple sources

Pregnant or postpartum patients receiving magnesium therapy for pre-eclampsia who develop concerning symptoms should contact their maternity unit or obstetric team immediately.

High-risk groups who should discuss magnesium intake with their healthcare provider include individuals with chronic kidney disease (particularly stages 3–5), elderly patients taking multiple medications, those with reduced gastrointestinal motility, and anyone receiving regular magnesium therapy for conditions such as pre-eclampsia or cardiac arrhythmias.

Patients prescribed magnesium supplementation for deficiency should attend scheduled blood test monitoring as recommended by their clinician. If you have kidney disease, always inform healthcare professionals before taking any new supplements or over-the-counter medications, as many contain magnesium. Regular medication reviews with your GP or pharmacist can help identify potential sources of excess magnesium intake and prevent accumulation before symptoms develop.

Preventing Magnesium Overload

Prevention of hypermagnesaemia centres on appropriate use of magnesium-containing products, awareness of risk factors, and regular monitoring in susceptible individuals. For most people with normal kidney function, preventing magnesium overload is straightforward, but certain populations require particular vigilance.

Appropriate supplementation practices are essential. Magnesium supplements should only be taken when clinically indicated, such as for documented deficiency confirmed by blood tests, or for specific medical conditions under healthcare supervision. The NHS recommends that adults should not take more than 400 mg of magnesium from supplements daily unless advised by a doctor, as higher doses can cause diarrhoea and, in susceptible individuals, contribute to elevated levels. Always follow the dosage instructions provided by your healthcare professional or on the product label, and avoid taking multiple magnesium-containing products simultaneously without medical advice.

Medication awareness is crucial for prevention. Many over-the-counter preparations contain significant amounts of magnesium, including:

• Antacids (e.g., magnesium hydroxide, magnesium trisilicate)

• Laxatives (particularly magnesium sulphate, commonly known as Epsom salts)

• Some multivitamin and mineral supplements

• Certain indigestion remedies

Read product labels carefully and consult your pharmacist if uncertain about magnesium content. Patients with moderate to severe kidney disease should avoid magnesium-containing laxatives and antacids unless specifically advised by their clinician, pharmacist, or renal team, opting for alternative preparations when needed.

Regular monitoring is essential for high-risk individuals. Those with chronic kidney disease should have regular blood tests as recommended by their healthcare team, following NICE guidance for monitoring kidney function (eGFR and ACR). Serum magnesium levels are not routinely included in standard electrolyte panels (U&Es) but may be checked selectively in high-risk patients, those with symptoms, or individuals taking magnesium-containing medications.

Dietary considerations: whilst it is extremely difficult to consume excessive magnesium through diet alone in individuals with normal kidney function, those with severe kidney disease may need to moderate intake of very high-magnesium foods such as nuts, seeds, whole grains, and dark leafy vegetables. However, dietary restriction should only be implemented under guidance from a renal dietitian, as these foods provide important nutrients.

Patient education plays a vital role in prevention. If you have kidney disease, ensure all healthcare professionals (including dentists and pharmacists) are aware of your condition before recommending or prescribing any new medications or supplements. Maintain an up-to-date list of all medications, supplements, and over-the-counter products you take, and review this regularly with your GP or pharmacist to identify potential sources of excess magnesium.

Frequently Asked Questions